Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Cancer, Recurrent

Explore clinical trials studying Renal Cell Cancer, Recurrent. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Renal Cell Cancer, Recurrent trial results

Recruiting

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

NCT07197580

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
Locations
  • Westmead Hospital Sydney, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Austin Health Heidelberg, Victoria, Australia
  • Melbourne Theranostic Innovation Centre (MTIC) Melbourne N., Victoria, Australia
View Trial Details
Active, Not Recruiting

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

NCT03634540

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
Locations
  • USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States
  • Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States
  • Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
  • Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States
View Trial Details

Related conditions